Australia's most trusted
source of pharma news
Saturday, 12 July 2025
Posted 20 January 2021 AM
As part of its new transparency measures for prescription medicines, the TGA has begun publishing medicine applications that are under evaluation - information that has never been disclosed to the public before.
Starting this month, the regulatory body is publishing details of major innovator medicines that have been accepted and are under evaluation, excluding applications for new generic and biosimilar medicines.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.